A new study published in JAMA Network Open by Hanna Heyman and colleagues provides important insights into how colorectal ...

FOBT-positive patients who skipped colonoscopy had fourfold higher cancer incidence ...

Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...

June 8, 2009 (Chicago, Illinois) – Detection of "long DNA" in the stool, when combined with fecal occult blood testing, detects colorectal cancers with a specificity of 90%. This approach is "among ...

When David Thau, a lobbyist in Washington, D.C., was 34, he periodically experienced pain in his stomach, irregular bowel movements, blood in his stool and vomiting, and he visited doctors ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

Fewer than half of adults have a follow-up colonoscopy within six months following an abnormal stool-based screening test (SBT) for colorectal cancer (CRC), according to a study published online March ...

Analyzing data gathered between 2000 and 2008, researchers observed a significant decline in FOBT prevalence in higher socioeconomic status groups, but not in lower socioeconomic status groups. During ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...

Colorectal cancer is one of the leading causes of cancer-related deaths in Kentucky, and it often doesn't cause symptoms, especially in its early stages. Regular screening, beginning at age 45, is the ...